ZURICH, Jan 14 (Reuters) - A new Swiss production line where contract drugmaker Lonza (LONN.S), opens new tab is making active ingredients for Moderna's (MRNA.O), opens new tab COVID-19 vaccine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback